Bavana V. Rangan, BDS, MPH, MD

Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention

;

Michaella Alexandrou , MD;

Dimitrios Strepkos , MD;

;

Olga C. Mastrodemos , BA;

Ahmed Al-Ogaili , MD;

M. Nicholas Burke , MD;

Yader Sandoval , MD;

;

The authors evaluated the JR-CTO score’s performance in patients treated at 44 centers between 2013 and 2024 as part of the Prospective Global Registry for the Study of CTO Intervention (PROGRESS-CTO).

The authors evaluated the JR-CTO...

08/14/2024

Journal of Invasive Cardiology

Original Contribution

08/09/2024

Michaella Alexandrou , MD;

;

Ahmed Al-Ogaili , MD;

Pedro E.P. Carvalho , MD;

Dimitrios Strepkos , MD;

James W. Choi , MD;

;

Khaldoon Alaswad , MD;

;

Philip Dattilo , MD;

Anthony H. Doing , MD;

Lorenzo Azzalini , MD, PhD, MSc;

Nazif Aygul , MD;

Raj Chandwaney , MD;

;

Sevket Gorgulu , MD;

Artificial Intelligence for Predicting Primary Antegrade Wiring Success of Chronic Total Occlusion Crossing

Laura D. Young , MD;

Oleg Krestyaninov , MD;

Dmitrii Khelimskii , MD;

;

Omer Goktekin , MD;

James D. Flaherty , MD;

Daniel R. Schimmel , MD, MS;

Keith H. Benzuly , MD;

Mahmut Uluganyan , MD;

Ramazan Ozdemir , MD;

Yousif Ahmad , MRCP, PhD, FSCAI, FACC, BMBS;

;

Olga C. Mastrodemos , BA;

M. Nicholas Burke , MD;

;

Yader Sandoval , MD;

;

The authors examined a multicenter registry of CTO PCI to explore the prevalence of peripheral artery disease and its effects on techniques used during the procedure and in-hospital outcomes.

The authors examined a...

08/09/2024

Journal of Invasive Cardiology

Original Contribution

09/30/2024

Michaella Alexandrou , MD;

;

Dimitrios Strepkos , MD;

Pedro E.P. Carvalho , MD;

Ahmed Al-Ogaili , MD;

;

Ioannis Tsiafoutis , MD;

Khaldoon Alaswad , MD;

;

;

Lorenzo Azzalini , MD, PhD, MSc;

Sevket Gorgulu , MD;

Impact of Intravascular Ultrasound Utilization for Stent Optimization on 1-Year Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention

Sripal Bangalore , MD, MHA;

;

Olga C. Mastrodemos , BA;

M. Nicholas Burke , MD;

Yader Sandoval , MD;

;

The authors compared the predictions for successful antegrade wiring of chronic total occlusion lesions made by interventional cardiologists with those from a machine learning model.

The authors compared the...

09/30/2024

Journal of Invasive Cardiology

09/30/2020

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Raj Chandwaney , MD;

Nicholas J. Lembo , MD;

Abdul M. Sheikh , MD;

Anthony H. Doing , MD;

Fotios Gkargkoulas , MD;

Catalin Toma , MD;

Mohamed Omer , MD;

Larissa Stanberry , PhD;

Iosif Xenogiannis , MD;

Ross F. Garberich , MS, MBA, MD;

Habib Samady , MD;

Philip Dattilo , MD;

Jeffrey W. Moses , MD;

Evangelia Vemmou , MD;

Michael S. Megaly , MD, MS;

Ziad A. Ali , MD, DPhil;

Ilias Nikolakopoulos , MD;

Brian K. Jefferson , MD, FACC, FSCAI;

Manish A. Parikh , MD;

Santiago Garcia , MD;

Taral N. Patel , MD;

M. Nicholas Burke , MD;

Ajay J. Kirtane , MD, SM;

Practice Patterns in the Interventional Treatment of Coronary Bifurcation Lesions: A Global Survey

Khaldoon Alaswad , MD;

Wissam A. Jaber , MD;

Shuaib M. Abdullah , MD;

Dimitrios Karmpaliotis , MD, PhD;

The impact of intravascular ultrasound utilization for stent optimization on the long-term outcomes in chronic total occlusion percutaneous coronary intervention has received limited study.

The impact of intravascular...

09/30/2020

Journal of Invasive Cardiology

Original Contribution

01/03/2022

M. Nicholas Burke , MD;

Kevin J. Croce , MD, PhD;

Yiannis S. Chatzizisis , MD, PhD;

Hani Jneid , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Lorenzo Azzalini , MD, PhD, MSc;

Brian A. Bergmark , MD;

Jason Wollmuth , MD;

Allison Hall , MD;

Judit Karacsonyi , MD, PhD;

Recurrent Cardiovascular Events with Paclitaxel-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Lesions: Insights from the SOS (Stenting of Saphenous Vein Grafts) Trial

Evangelia Vemmou , MD;

Ilias Nikolakopoulos , MD;

The study aim was to assess current procedural strategies and perceptions for percutaneous coronary intervention (PCI) involving bifurcations.

The study aim was to assess...

01/03/2022

Journal of Invasive Cardiology

Original Contribution

05/26/2011

Tesfaldet T. Michael , MD, MPH;

Donald Haagen , RCIS, MD;

Tayo Addo , MD;

Aristotelis C. Papayannis , MD;

Abdul-Rahman Abdel-Karim , MD;

Bilal Saeed , MD;

Panagiotis Karyofillis , MD;

Biswajit Kar , MD;

Peter B. Berger , MD;

Christopher Lichtenwalter , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Owen Obel , MD;

Joseph K. Bissett , MD;

Rajesh Sachdeva , MD;

Vassilios V. Voudris , MD, PhD;

Michele Roesle , RN, BSN, MD;

James Rossen , MD;

A Meta-Analysis of Contemporary Lesion Modification Strategies During Percutaneous Coronary Intervention in 244,795 Patients From 22 Studies

Panayotis Fasseas , MD;

James A. de Lemos , MD;

ABSTRACT: The Stenting of Saphenous Vein Grafts (SOS) trial demonstrated a reduction in clinical and angiographic adverse events with paclitaxel-eluting stents (PES) compared to bare-metal stents (BMS) in saphenous vein graft (SVG) lesions,...

ABSTRACT: The Stenting of...

05/26/2011

Journal of Invasive Cardiology

Original Contribution

07/15/2017

Aris Karatasakis , MD;

Barbara Anna Danek , MD;

Judit Karacsonyi , MD, PhD;

Michele Roesle , RN, BSN, MD;

M. Nicholas Burke , MD;

Waleed Alharbi , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial

Outcomes with use of lesion-modification strategies in the drug-eluting stent era have received limited study. We conducted a meta-analysis of 22 studies published between 2004-2016 reporting outcomes after use of rotational atherectomy,...

Outcomes with use of...

07/15/2017

Journal of Invasive Cardiology

Original Contribution

10/01/2015

Anna P. Kotsia , MD, PhD;

Georgios Christopoulos , MD;

James A. de Lemos , MD;

Darren K. McGuire , MD, MHSc;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Milton Packer , MD;

Daisha J. Cipher , PhD, MD;

Michele Roesle , RN, BSN, MD;

Lesion Complexity and Procedural Outcomes Associated With Ostial Chronic Total Occlusions: Insights From the PROGRESS-CTO Registry

Ameka Coleman , MS, BS;

Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.

Intermediate SVG lesions have...

10/01/2015

Journal of Invasive Cardiology

Original Contribution

07/13/2023

Yader Sandoval , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Judit Karacsonyi , MD, PhD;

Michalis Koutouzis , MD, PhD;

Dimitrios Karmpaliotis , MD, PhD;

Basem Elbarouni , MD;

Ehtisham Mahmud , MD;

Mitul P. Patel , MD;

Bahadir Simsek , MD;

M. Nicholas Burke , MD;

Spyridon Kostantinis , MD;

Long-Term Outcomes With Use of the CrossBoss and Stingray Coronary CTO Crossing and Re-Entry Devices

Omer Goktekin , MD;

Salman S. Allana , MD;

Khaldoon Alaswad , MD;

Paul Poommipanit , MD, FACC, FSCAI;

Wissam A. Jaber , MD;

Sevket Gorgulu , MD;

William J. Nicholson , MD;

Stéphane Rinfret , MD, SM;

Oleg Krestyaninov , MD;

Dmitrii Khelimskii , MD;

Nidal Abi Rafeh , MD;

Ahmed M. ElGuindy , MD, MSc, FRCP;

Ioannis Tsiafoutis , MD;

We examined the clinical and angiographic characteristics and procedural outcomes of 8,788 CTO PCIs performed at 35 US and non-US centers between 2012 and 2022. In-hospital major adverse cardiac events (MACE) included death, myocardial...

We examined the clinical and...

07/13/2023

Journal of Invasive Cardiology

Original Contribution

10/30/2013

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Tesfaldet T. Michael , MD, MPH;

Mohammed E. Alomar , MD;

Shuaib M. Abdullah , MD;

Vishal G. Patel , MD;

Owen Mogabgab , MD;

Eric Fuh , MD;